Fake Drug Network Sparks Nationwide Alert Over High Value Cancer Medicines
A suspected fake drug network uncovered near Bengaluru may have links across several states, prompting authorities to inspect medicine stocks and verify expensive cancer drugs.
Fake drug network suspected across several states
Cancer medicines are among the key targets
Nationwide checks have been ordered
A suspected counterfeit medicine network uncovered near Bengaluru has raised concerns over the circulation of fake and mislabelled drugs in several parts of the country. Authorities suspect the operation may have links to Telangana, Himachal Pradesh and Mumbai, prompting a wider alert to drug regulators.
The case came to light after Karnataka’s drug enforcement officials raided an allegedly unlicensed manufacturing unit near Bidadi on August 18. The operation took place at No 34 Kurubarahalli village, where officials reportedly found counterfeit medicines, bulk stocks, packaging equipment, empty vials and fake labels.
The estimated value of the seized material was put at around Rs 5.05 crore, according to the information provided by the drug control authorities.
The suspected network has caused particular concern because expensive medicines used in cancer treatment and other serious illnesses were allegedly being targeted. Officials have therefore asked hospitals, doctors, pharmacies and distributors to remain especially cautious while purchasing high value medicines.
The Karnataka drug control department has alerted drug controllers and state licensing authorities across the country. States have been asked to check whether medicines carrying suspicious labels or batches restricted in Karnataka are being sold or distributed in their markets.
Checks have also been recommended at major wholesale medicine markets, distribution centres and retail pharmacies. Distributors dealing in costly imported medicines have been asked to maintain proper purchase invoices, batch records and documents showing the source of their stock.
Investigators suspect that inexpensive generic medicines sourced from manufacturing centres in Telangana and Himachal Pradesh may have been brought to Karnataka. The medicines were allegedly repackaged into new vials at an unlicensed facility and given labels that made them appear to be expensive imported products.
The involvement of well known pharmaceutical brands has added another layer of concern. Officials reportedly found medicines and packaging carrying the name of Pfizer, along with labels and empty vials associated with several other drug brands.
Among the materials reportedly seized were packaging linked to Aztreonam and Avibactam, Ceftazidime and Avibactam, Tigecycline and Midazolam injections. Empty vials and labels carrying names including Zavicefta, Xavitaz, Trezam and AztraQ were also reportedly recovered.
The findings suggest that the facility may not have been limited to storing suspicious medicines. Investigators are also examining whether a complete repackaging and relabelling operation was being run from the premises.
Doctors, oncologists and pharmacies have been advised to carefully examine the packaging and authenticity features of expensive imported medicines. Any medicine with unusual packaging, missing batch information or an unclear supply source is expected to be reported to the authorities.
The suspected interstate connections have now widened the scope of the investigation. Authorities are expected to carry out checks across wholesale markets, distributors and medical shops as they try to determine how far the alleged counterfeit supply chain had spread.
Fake drugs can pose serious risks to patients, particularly when they involve medicines used for cancer and other critical conditions. The nationwide alert is aimed at identifying suspicious stocks before they reach more patients.
